New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2014
08:48 EDTFMIFoundation Medicine data to have positive effect on reimbursement, says Wedbush
After clinical data on gene fusion detection indicated that such detection led to clinical action in about 15% of patients, Wedbush thinks the 15% level will be more than enough for large payors to recognize the importance of deep tumor profiling in some patients. The firm thinks the recent increase in reimbursement rates for BRCA pricing is positive for long-term FoundationOne reimbursement. Wedbush keeps a $50 price target and Outperform rating on Foundation Medicine.
News For FMI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
07:27 EDTFMIFoundation Medicine has a conference call hosted by JPMorgan
Subscribe for More Information
May 13, 2015
07:28 EDTFMIFoundation Medicine price target lowered to $48-52 from $60-65 at Wells Fargo
Subscribe for More Information
07:06 EDTFMIFoundation Medicine announces new data on FoundationOne assay
Subscribe for More Information
May 12, 2015
08:20 EDTFMIFoundation Medicine weakness creates buying opportunity, says JMP Securities
Subscribe for More Information
May 11, 2015
18:29 EDTFMIAffordable Care Act guidance says insurers must cover BRCA1, BRCA2 testing
The United States Department of Labor issued updated Affordable Care Act guidance, which mandates that health insurers must cover testing for breast and ovarian cancer through analysis of the BRCA1 and BRCA2 genes. Myriad (MYGN), Foundation Medicine (FMI), and Genomic Health (GHDX) compete in the genetic testing space. Reference Link
16:03 EDTFMIFoundation Medicine reports 7,854 clinical tests in Q1, up 67% y/y
Subscribe for More Information
16:02 EDTFMIFoundation Medicine sees FY15 revenue $105M-$115M, consensus $108.73M
Subscribe for More Information
16:01 EDTFMIFoundation Medicine reports Q1 EPS (59c), consensus (53c)
Reports Q1 revenue $19.3M, consensus $20.98M.
15:00 EDTFMINotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use